Back to search

Article

β-Nicotinamide mononucleotide: a novel broad-spectrum CRISPR inhibitor

2025-11-26

Abstract excerpt

CRISPR–Cas systems have revolutionized genome editing with their precision and versatility, enabling transformative applications in various fields, especially in the treatment of genetic diseases. However, the clinical translation of this technology is hindered by challenges such as off-target effects and uncontrolled nuclease activity. At the same time, it has the possibility of causing biosecurity risks, undersc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f5b69608-0ea3-580f-b15d-d64ffdf477cc
DOI
10.1101/2025.11.22.685598
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
β-Nicotinamide mononucleotide: a novel broad-spectrum CRISPR inhibitorDOI 10.1101/2025.11.22.685598
Select a neighboring publication to make it the new centre.